Cimeio Therapeutics (private company)
See something wrong or missing? Let us know
Offices:Basel
Industry:BiotechHealth servicesManufacturing
Business model:B2B
Cimeio Therapeutics is a Swiss biotech company that develops curative treatments for genetic diseases, hematologic malignancies, and severe autoimmune disorders.
Investors:
we tracked 1 investor
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 50M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Cimeio Therapeutics
Name | Criteria | |
---|---|---|
![]() |
CatalYm
58%
|
|
![]() |
InnovaFeed SAS
58%
|
|
![]() |
Memo Therapeutics
58%
|
|
![]() |
Peptomyc
58%
|
|
![]() |
Salvia BioElectronics
58%
|
|
![]() |
Synendos Therapeutics
58%
|
|
![]() |
Cytoki Pharma
58%
|
|
![]() |
AMSilk
58%
|
|
![]() |
Xenothera
58%
|
|
![]() |
Eyevensys
58%
|
|